☆ 4.8 Article

Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape

NATURE COMMUNICATIONS (2022)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2

Pengcheng Han et al.

Summary: The study found that the omicron variant, unlike other variants, has a similar affinity to the human receptor ACE2 as the prototype variant. Multiple mutations in the omicron variant may compensate for both immune escape and transmissibility. The complex structures of the omicron and delta variants binding to ACE2 provide insights into how specific mutations affect the binding.

CELL (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron

Zhen Cui et al.

Summary: The Omicron variant of SARS-CoV-2 is spreading rapidly worldwide due to its increased fitness, with spike structures that maintain stability for receptor recognition but compromise viral fusion efficiency. By altering amino acids and structures, it evades recognition by most antibodies, facilitating immune escape. The research sheds light on conserved regions for the development of broad-spectrum vaccines.

CELL (2022)

Add to Collection

Article Multidisciplinary Sciences

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

Delphine Planas et al.

Summary: The Omicron variant of SARS-CoV-2, identified in November 2021, has spread rapidly worldwide and shows resistance to most therapeutic monoclonal antibodies and vaccine-elicited antibodies. However, it can be neutralized by antibodies generated by a booster vaccine dose.

NATURE (2022)

Add to Collection

Article Multidisciplinary Sciences

Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants

Kang Wang et al.

Summary: The Omicron variant of SARS-CoV-2 is highly resistant to neutralizing antibodies, which raises concerns about the effectiveness of antibody therapies and vaccines. A study found that individuals who received two or three doses of an inactivated SARS-CoV-2 vaccine had varying rates of seroconversion for neutralizing antibodies. The effectiveness of neutralizing antibodies against Omicron was significantly lower in individuals who received three vaccine doses. However, monoclonal antibodies derived from individuals who received three vaccine doses showed strong neutralizing activity against all variants of concern, including Omicron.

NATURE (2022)

Add to Collection

Article Multidisciplinary Sciences

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

Yunlong Cao et al.

Summary: The Omicron variant of SARS-CoV-2 contains 15 mutations in the receptor-binding domain, leading to evasion of over 85% of tested neutralizing antibodies. Different epitope groups of neutralizing antibodies are affected to varying degrees by single mutations of Omicron. Antibodies targeting the conserved region of sarbecovirus remain most effective against Omicron.

NATURE (2022)

Add to Collection

Article Multidisciplinary Sciences

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

Lihong Liu et al.

Summary: The B.1.1.529/Omicron variant of SARS-CoV-2, initially detected in southern Africa, has rapidly spread globally and is expected to become dominant due to its enhanced transmissibility in the coming weeks. This variant poses a threat to the efficacy of current COVID-19 vaccines and antibody therapies due to its significant antibody resistance. Even individuals who have received vaccines and booster doses may have reduced neutralizing activity against B.1.1.529.

NATURE (2022)

Add to Collection

Letter Medicine, General & Internal

Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant

Xin Zhao et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex

Dhiraj Mannar et al.

Summary: The newly reported Omicron variant shows new salt bridges and hydrogen bonds formed by mutated residues in the receptor binding domain, compensating for reduced ACE2 binding affinity. It also exhibits increased antibody evasion, which likely contributes to its rapid spread.

SCIENCE (2022)

Add to Collection

Article Multidisciplinary Sciences

Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody

Wanchao Yin et al.

Summary: The structures of the Omicron spike trimer and its interactions with ACE2 and an anti-Omicron antibody are reported. Most mutations in Omicron are located on the spike protein surface, altering binding to many existing antibodies. Compensating mutations in the ACE2-binding site enhance binding to ACE2. The therapeutic antibody JMB2002 maintains neutralizing activity against Omicron and inhibits ACE2 binding.

SCIENCE (2022)

Add to Collection

Article Cell Biology

Cryo-EM structure of the SARS-CoV-2 Omicron spike

Gabriele Cerutti et al.

Summary: The Omicron variant of SARS-CoV-2, known for its high ability to evade neutralizing antibodies, has been found to have 34 mutations in the spike protein, with 15 of them occurring in the receptor-binding domain (RBD). A cryo-EM structure of the Omicron spike protein reveals that it is exclusively in the 1-RBD-up conformation, with high mobility of RBD. These mutations in the spike protein cause steric clashes and altered interactions at antibody-binding surfaces, as well as changes in local regions that interfere with antibody recognition.

CELL REPORTS (2022)

Add to Collection

Article Immunology

The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron

Youchun Wang et al.

Summary: The Omicron variant shows greater potential for immune escape compared to other variants, suggesting a significant impact on immunity from previous infections and vaccines.

EMERGING MICROBES & INFECTIONS (2022)

Add to Collection

Article Multidisciplinary Sciences

Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement

Matthew McCallum et al.

Summary: The SARS-CoV-2 Omicron variant evades antibody-mediated immunity and exhibits enhanced affinity for host cells due to accumulation of spike mutations and remodeling of interactions with the ACE2 receptor.

SCIENCE (2022)

Add to Collection

Article Multidisciplinary Sciences

Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain

Gang Ye et al.

Summary: The omicron variant of SARS-CoV-2 has a stable open conformation of the spike protein, making it more efficient in cell entry and immune evasion compared to previous variants.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Cell Biology

Broader-species receptor binding and structural bases of Omicron SARS-CoV-2 to both mouse and palm-civet ACE2s

Linjie Li et al.

Summary: The Omicron variant of SARS-CoV-2 has multiple unusual mutations, especially in the receptor-binding domain (RBD) of the spike (S) protein. It has expanded its receptor binding range to various species, suggesting the need for enhanced surveillance to prevent further transmission. Structural analysis has identified key residues for host recognition. These findings highlight the importance of monitoring the Omicron variant to contain the pandemic.

CELL DISCOVERY (2022)

Add to Collection

Review Medicine, Research & Experimental

SARS-CoV-2 Omicron variant: Immune escape and vaccine development

Danyi Ao et al.

Summary: This article investigates the epidemiological characteristics and immune escape mechanisms of the new variant of concern, Omicron, and proposes therapeutic strategies against it, aiming to provide information for further research efforts to prevent and contain the impact of new variants of concern during the ongoing pandemic.

MEDCOMM (2022)

Add to Collection

Article Biology

DeepEMhancer: a deep learning solution for cryo-EM volume post-processing

Ruben Sanchez-Garcia et al.

Summary: Sanchez-Garcia et al. introduce DeepEMhancer, a deep learning-based method for automatic post-processing of raw cryo-electron microscopy density maps. It globally improves local quality of density maps and shows potential as a useful tool for structures without readily available PDB models.

COMMUNICATIONS BIOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Evidence for a mouse origin of the SARS-CoV-2 Omicron variant

Changshuo Wei et al.

Summary: The study suggests that the rapid accumulation of mutations in the SARS-CoV-2 Omicron variant may have originated from humans jumping to mice and then back to humans, indicating an inter-species evolutionary trajectory.

JOURNAL OF GENETICS AND GENOMICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape

Qianqian Li et al.

Summary: The 501Y.V2 variants of SARS-CoV-2 with multiple mutations are rapidly spreading from South Africa to other countries, showing reduced susceptibility to neutralizing antibodies and potential compromise of monoclonal antibodies and vaccines. Enhanced infectivity in murine ACE2-overexpressing cells suggests the possibility of transmission to mice.

CELL (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

Wilfredo F. Garcia-Beltran et al.

Summary: New variants of SARS-CoV-2 show high resistance to vaccine neutralization, with some able to escape vaccine responses with just a few mutations, highlighting the importance of developing broadly protective measures against variants.

CELL (2021)

Add to Collection

Article Multidisciplinary Sciences

Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant

Jun Zhang et al.

Summary: The Delta variant of SARS-CoV-2 is more efficient at fusing membranes at low levels of cellular receptor ACE2, possibly contributing to its heightened transmissibility. Each variant shows different rearrangement of the antigenic surface of the S protein, but only the changes in the RBD make it a better target for therapeutic antibodies.

SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2

Donald J. Benton et al.

Summary: Studies indicate that the G614 mutant spike adopts more open conformations, which may facilitate binding to the SARS-CoV-2 receptor ACE2 and the subsequent structural rearrangements required for viral membrane fusion.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Add to Collection

Article Multidisciplinary Sciences

Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera

Alexander Muik et al.

Summary: A new SARS-CoV-2 lineage B.1.1.7 has emerged in the UK, which is more transmissible and faster spreading than other strains. However, a study found that the BNT162b2 vaccine offers largely preserved protection against the B.1.1.7 lineage, despite some reduced neutralizing titers.

SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

Conformational dynamics of the Beta and Kappa SARS-CoV-2 spike proteins and their complexes with ACE2 receptor revealed by cryo-EM

Yifan Wang et al.

Summary: The study provides insights into the conformational dynamics of Beta and Kappa SARS-CoV-2 spike proteins, showing a shift towards the open state and increased binding to ACE2 receptors. These variants exhibit enhanced transmissibility and resistance to neutralizing antibodies, posing challenges for controlling the ongoing COVID-19 pandemic. The structural analysis reveals potential modifications in receptor binding kinetics and viral fusion, as well as an expanded landscape for the S-ACE2 complexes, shedding new light on the pathogenicity and immune evasion mechanisms of the Beta and Kappa variants.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants

Pengcheng Han et al.

Summary: Multiple SARS-CoV-2 variants, including Alpha, Beta, and Gamma, were studied in terms of their interactions with the human ACE2 receptor. The study identified key residues in the receptor-binding domain that affect binding affinity and demonstrated the potential of soluble ACE2 protein in preventing viral entry. The findings could contribute to the development of novel therapeutic and prophylactic agents targeting these emerging mutants.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Cell Biology

Structural analysis of receptor binding domain mutations in SARS-CoV-2 variants of concern that modulate ACE2 and antibody binding

Dhiraj Mannar et al.

Summary: The newly emerged SARS-CoV-2 variants, Beta and Gamma, exhibit key mutations that enhance spike protein affinity for ACE2 receptor and promote antibody evasion. By engineering spike proteins with these mutations and conducting structural analyses, the effects of different variants were studied in terms of increased ACE2 affinity and antibody evasion.

CELL REPORTS (2021)

Add to Collection

Letter Cell Biology

The basis of a more contagious 501Y.V1 variant of SARS-CoV-2

Haolin Liu et al.

CELL RESEARCH (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies

Xing Zhu et al.

Summary: The UK variant of SARS-CoV-2 with the N501Y mutation shows increased infectivity due to tighter binding with the ACE2 receptor, but without significant structural changes. Important neutralization epitopes in the spike receptor binding domain are retained.

PLOS BIOLOGY (2021)

Add to Collection

Article Cell Biology

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines

Yunlong Cao et al.

Summary: The study found that the diversity of anti-RBD NAbs plays a major role in neutralization against SARS-CoV-2 variants, especially 501Y.V2, with E484K being the dominant cause of neutralization reduction. Specific antibodies respond differently to mutations in RBD variants, with lower diversity observed in NTD antibodies. RBD-subunit vaccinees exhibit higher tolerance to neutralization against variants, while extending the interval between doses of ZF2001 enhances neutralizing activity and tolerance to variants.

CELL RESEARCH (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Experimental Evidence for Enhanced Receptor Binding by Rapidly Spreading SARS-CoV-2 Variants

Charlie Laffeber et al.

Summary: Different mutations in new variants of SARS-CoV-2 have varying effects on receptor binding affinity, viral transmission, and immune evasion, highlighting the importance of global viral genome surveillance and functional characterization.

JOURNAL OF MOLECULAR BIOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function

Tzu-Jing Yang et al.

Summary: The spike protein of the SARS-CoV-2 B.1.1.7 variant exhibits mutations that affect virus binding to the host ACE2 receptor and immune evasion. The A570D and N501Y mutations have been shown to impact the stability of the spike protein structure, and an introduced neutralizing antibody can effectively neutralize different strains of the virus.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study

Kathryn M. Hastie et al.

Summary: Antibody-based therapeutics and vaccines are crucial in combating COVID-19, especially with mutations and transmission of SARS-CoV-2. An international consortium identified multiple RBD-directed antibody communities, providing a framework for selecting treatment cocktails.

SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants

Yongfei Cai et al.

Summary: The study found that the B.1.1.7 variant has increased receptor binding affinity, while the B.1.351 variant has developed resistance to some neutralizing antibodies by reshaping antigenic surfaces on the spike protein.

SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

The molecular basis for SARS-CoV-2 binding to dog ACE2

Zengyuan Zhang et al.

Summary: The study found that the spike protein receptor binding domain (RBD) of SARS-CoV-2 can bind to the receptor of dog angiotensin-converting enzyme 2 (dACE2), allowing both pseudotyped and authentic SARS-CoV-2 to infect cells expressing dACE2. Additionally, important mutations in the RBD binding interface are identified to play a pivotal role in the binding affinity of RBD to both dACE2 and hACE2, providing insights into potential animal spread and cross-species transmission of SARS-CoV-2.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Biology

Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics

Michael Barton et al.

Summary: The study analyzed the effects of mutations in the Spike protein of SARS-CoV-2 on its interaction with ACE2, finding that most mutations increased affinity with ACE2. Two ACE2 mutations were also found to enhance binding with the Spike protein.

ELIFE (2021)

Add to Collection

Article Biology

N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2

Fang Tian et al.

Summary: Research indicates that the N501Y mutation in SARS-CoV-2 variants strengthens its interaction with ACE2, leading to an increased transmission rate, highlighting the need for close monitoring of future mutations in the virus' RBD.

ELIFE (2021)

Add to Collection

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

Qihui Wang et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Alexandra C. Walls et al.

CELL (2020)

Add to Collection

Article Multidisciplinary Sciences

Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody

Dora Pinto et al.

NATURE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding

Tyler N. Starr et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

Luca Piccoli et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects

Antoni G. Wrobel et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy

Hongjing Gu et al.

SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion

Donald J. Benton et al.

NATURE (2020)

Add to Collection

Article Microbiology

Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains

Tongqing Zhou et al.

CELL HOST & MICROBE (2020)

Add to Collection

Editorial Material Biochemistry & Molecular Biology

Breathing Hemagglutinin Reveals Cryptic Epitopes for Universal Influenza Vaccine Design

Yan Wu et al.

CELL (2019)

Add to Collection

Article Biochemistry & Molecular Biology

A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface

Sandhya Bangaru et al.

CELL (2019)

Add to Collection

Article Multidisciplinary Sciences

Transient opening of trimeric prefusion RSV F proteins

Morgan S. A. Gilman et al.

NATURE COMMUNICATIONS (2019)

Add to Collection

Article Biochemistry & Molecular Biology

UCSF ChimeraX: Meeting modern challenges in visualization and analysis

Thomas D. Goddard et al.

PROTEIN SCIENCE (2018)

Add to Collection

Article Biochemistry & Molecular Biology

MolProbity: More and better reference data for improved all-atom structure validation

Christopher J. Williams et al.

PROTEIN SCIENCE (2018)

Add to Collection

Review Immunology

Probing Structural Variation and Dynamics in the HIV-1 Env Fusion Gly- coprotein

James B. Munro et al.

CURRENT HIV RESEARCH (2018)

Add to Collection

Article Biology

New tools for automated high-resolution cryo-EM structure determination in RELION-3

Jasenko Zivanov et al.

ELIFE (2018)

Add to Collection

Review Biochemistry & Molecular Biology

The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design

Felix A. Rey et al.

EMBO REPORTS (2018)

Add to Collection

Letter Biochemical Research Methods

MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy

Shawn Q. Zheng et al.

NATURE METHODS (2017)

Add to Collection

Article Biochemical Research Methods

cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination

Ali Punjani et al.

NATURE METHODS (2017)

Add to Collection

Article Multidisciplinary Sciences

Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains

Yuan Yuan et al.

NATURE COMMUNICATIONS (2017)

Add to Collection

Article Biochemistry & Molecular Biology

CTFFIND4: Fast and accurate defocus estimation from electron micrographs

Alexis Rohou et al.

JOURNAL OF STRUCTURAL BIOLOGY (2015)

Add to Collection

Article Biochemical Research Methods

PHENIX: a comprehensive Python-based system for macromolecular structure solution

Paul D. Adams et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)

Add to Collection

Article Biochemical Research Methods

Coot:: model-building tools for molecular graphics

P Emsley et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)

Add to Collection

Article Chemistry, Multidisciplinary

UCSF chimera - A visualization system for exploratory research and analysis

EF Pettersen et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.